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Individuality in cutaneous gene expression: 
implications for topical drug treatment
Responses to topical drugs 
used to treat common skin 
diseases are unpredictable 
and may potentially be ratio-
nalized by interindividual 
differences in the expression 
of cutaneous drug-metabo-
lizing  enzymes. Smith et 
al. used quantitative real-
time reverse transcription–
polymerase chain reaction 
analysis to demonstrate that 
topical coal tar, all-trans 
retinoic acid (Figure) and 
clobetasol 17-propionate 
modulated gene expres-
sion in healthy human skin in vivo. Marked individuality in 
gene regulation was seen for the majority of genes examined. 
Variation in cutaneous drug-metabolizing enzyme expression 
may therefore contribute to individuality in response to topi-
cal therapies for common skin diseases. Br J Dermatol 2006; 
155:275–281.
Increased expression of the natural killer cell 
inhibitory receptor CD94/NKG2A and CD158b 
on circulating and lesional T cells in patients 
with chronic plaque psoriasis
Natural killer receptor-expressing T cells are suggested to play 
a role in psoriasis. Liao et al. reported a significant increase 
of inhibitory CD8+ CD158b+, CD4– CD8– CD158b+ 
and CD8+ CD94/
NKG2A+ T cells 
in the peripheral 
blood of patients 
with psoriasis when 
compared with 
controls. Tissue-
infiltrating T lym-
phocytes express-
ing CD158b, CD94 
and NKG2A were 
found in psoriatic lesions. Furthermore, there was a signifi-
cant positive correlation between the increased percentage 
of circulating CD8+ CD94/NKG2A+ T cells and the Psoriasis 
Area and Severity Index. These findings may signify the pos-
sibility of chronic antigen-driven stimulation and dysregu-
lated cytokine production in the pathogenesis of psoriasis. 
Br J Dermatol 2006; 155:318–324.
BAFF in bullous pemphigoid
Recent advances in autoimmune diseases have elucidated 
that BAFF, a tumour necrosis factor superfamily member that 
regulates B lymphocyte proliferation and survival, plays a criti-
cal role. Asashima and coworkers found significant elevations 
of serum BAFF levels in patients 
with bullous pemphigoid (BP), 
but not in those with pemphigus, 
compared with normal controls. 
Although there was apparently no 
significant association between 
the BAFF levels and anti-BP180 
antibody titres in BP, BAFF levels 
tended to increase before the anti-
BP180 antibody levels increased at 
the very beginning of BP. BAFF may 
thus be involved in the pathogene-
sis of autoimmune bullous disease. 
Br J Dermatol 2006; 155:330–336.
Variability in the clinical pattern of cutaneous 
side-effects of drugs with systemic symptoms: 
does DRESS syndrome really exist?
The occurrence of drug-induced cutaneous side-effects 
with systemic symptoms may be a challenging situation 
in patients receiving multiple medications. In an attempt 
to help the identification of the culprit drug in this setting, 
the clinical and biological pattern of 216 patients receiv-
ing various inducing drugs was retrospectively analysed. 
Although this multiorgan drug-induced reaction appears as 
a constellation of various symptoms and no unified outline 
can therefore be defined, clinical and biological alterations 
may be arranged in different patterns according to the caus-
al drug, data that might prove clinically useful to improve 
the accurate identification of the culprit drug in patients 
receiving several important medications simultaneously. 
Br J Dermatol 2006; 155:422–428.
